Literature DB >> 24334113

Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration.

Carola I F Janssen1, Amanda J Kiliaan2.   

Abstract

Many clinical and animal studies demonstrate the importance of long-chain polyunsaturated fatty acids (LCPUFA) in neural development and neurodegeneration. This review will focus on involvement of LCPUFA from genesis to senescence. The LCPUFA docosahexaenoic acid and arachidonic acid are important components of neuronal membranes, while eicosapentaenoic acid, docosahexaenoic acid, and arachidonic acid also affect cardiovascular health and inflammation. In neural development, LCPUFA deficiency can lead to severe disorders like schizophrenia and attention deficit hyperactivity disorder. Perinatal LCPUFA supplementation demonstrated beneficial effects in neural development in humans and rodents resulting in improved cognition and sensorimotor integration. In normal aging, the effect of LCPUFA on prevention of cognitive impairment will be discussed. LCPUFA are important for neuronal membrane integrity and function, and also contribute in prevention of brain hypoperfusion. Cerebral perfusion can be compromised as result of obesity, cerebrovascular disease, hypertension, or diabetes mellitus type 2. Last, we will focus on the role of LCPUFA in most common neurodegenerative diseases like Alzheimer's disease and Parkinson's disease. These disorders are characterized by impaired cognition and connectivity and both clinical and animal supplementation studies have shown the potential of LCPUFA to decrease neurodegeneration and inflammation. This review shows that LCPUFA are essential throughout life.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1,2 diacylglycerol choline phosphotransferase; 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine; 5-LOX; 5-lipoxygenase; AD; ADAS-cog; ADHD; ADP; ALA; AMI; ARA; ATP; Alzheimer’s disease; Animal studies; Aβ; B12; B6; BBB; BDNF; BSID; Bayley Scales of Infant Development; CDP-choline; CDR; CIBIC-plus; CK; COX; CPT; CREB; CT; CTP; Clinical studies; DAG; DBS; DHA; DMII; EPA; FADS; GDNF; GLA; I-DOPA; I-dihydroxyphenylalanine; IQ; LA; LCPUFA; LDL; LT; Long-chain polyunsaturated fatty acids; MCI; MDI; MMSE; MPTP; MetS; NPD1; NPI; Neural development; Neurodegeneration; PC; PD; PDI; PE; PG; PPAR; PS; Parkinson’s disease; RAR; RBANS; RXR; SFA; SNpc; TX; Trk B; UTP; VEP; VLDL; acute myocardial infarction; adenosine diphosphate; adenosine triphosphate; arachidonic acid; attention deficit hyperactivity disorder; blood brain barrier; brain-derived neurotrophic factor; cAMP; cAMP response element binding protein; choline kinase; clinical dementia rating; clinician’s interview-based impression of change scale which included caregiver-supplied information; cognitive subscale of the Alzheimer’s disease assessment scale; cyclic adenosine monophosphate; cyclooxygenase; cytidine diphosphate choline; cytidine triphosphate; cytidine triphosphate-phosphocholine cytidyl transferase; deep brain stimulation; diabetes mellitus type 2; diacylglycerol; docosahexaenoic acid; eicosapentaenoic acid; fatty acid desaturase; glial cell-derived neurotrophic factor; intelligence quotient; leukotrienes; linoleic acid; long-chain polyunsaturated fatty acids; low density lipoprotein; mental development index; metabolic syndrome; mild cognitive impairment; mini-mental state examination; n-3 PUFA; n-6 PUFA; neuroprotectin D1; neuropsychiatric inventory; omega-3 polyunsaturated fatty acids; omega-6 polyunsaturated fatty acids; p.p.; peroxisome proliferator-activated receptor; phosphatidylcholine; phosphatidylethanolamine; phosphatidylserine; post partum; prostaglandins; psychomotor development index; randomized double blind placebo controlled; rdbpc; repeatable battery for the assessment of neuropsychological status; retinoic acid receptor; retinoid X receptor; saturated fatty acids; substantia nigra pars compacta; thromboxanes; tyrosine kinase B; uridine triphosphate; very low density lipoprotein; visual evoked potential; vitamin B12; vitamin B6; α-linolenic acid; β-amyloid; γ linolenic acid

Mesh:

Substances:

Year:  2013        PMID: 24334113     DOI: 10.1016/j.plipres.2013.10.002

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  127 in total

1.  Dietary pattern regulates fatty acid desaturase 1 gene expression in Indian pregnant women to spare overall long chain polyunsaturated fatty acids levels.

Authors:  Kalpana Joshi; Maithili Gadgil; Anand Pandit; Suhas Otiv; Kumar S D Kothapalli; J Thomas Brenna
Journal:  Mol Biol Rep       Date:  2018-12-03       Impact factor: 2.316

2.  Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials.

Authors:  Elizabeth Hawkey; Joel T Nigg
Journal:  Clin Psychol Rev       Date:  2014-06-02

3.  Genetic Variants of the FADS Gene Cluster Are Associated with Erythrocyte Membrane LC PUFA Levels in Patients with Mild Cognitive Impairment.

Authors:  J P Schuchardt; T Köbe; V Witte; J Willers; A Gingrich; V Tesky; J Pantel; D Rujescu; T Illig; A Flöel; A Hahn
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

4.  Evaluation of dietary intake in children and college students with and without attention-deficit/hyperactivity disorder.

Authors:  Kathleen F Holton; Jeanette M Johnstone; Elizabeth T Brandley; Joel T Nigg
Journal:  Nutr Neurosci       Date:  2018-01-23       Impact factor: 4.994

Review 5.  The potential relevance of docosahexaenoic acid and eicosapentaenoic acid to the etiopathogenesis of childhood neuropsychiatric disorders.

Authors:  Alessandra Tesei; Alessandro Crippa; Silvia Busti Ceccarelli; Maddalena Mauri; Massimo Molteni; Carlo Agostoni; Maria Nobile
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-12-17       Impact factor: 4.785

6.  Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls.

Authors:  Suzanne Medema; Roel J T Mocking; Maarten W J Koeter; Frédéric M Vaz; Carin Meijer; Lieuwe de Haan; Nico J M van Beveren; René Kahn; Lieuwe de Haan; Jim van Os; Durk Wiersma; Richard Bruggeman; Wiepke Cahn; Carin Meijer; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2015-09-18       Impact factor: 9.306

7.  Joint effects of fatty acid desaturase 1 polymorphisms and dietary polyunsaturated fatty acid intake on circulating fatty acid proportions.

Authors:  Juan Juan; Hongyan Huang; Xia Jiang; Andres V Ardisson Korat; Mingyang Song; Qi Sun; Walter C Willett; Majken K Jensen; Peter Kraft
Journal:  Am J Clin Nutr       Date:  2018-05-01       Impact factor: 7.045

8.  Biosynthetic mechanism of very long chain polyunsaturated fatty acids in Thraustochytrium sp. 26185.

Authors:  Dauenpen Meesapyodsuk; Xiao Qiu
Journal:  J Lipid Res       Date:  2016-08-15       Impact factor: 5.922

9.  Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.

Authors:  James F Markworth; Gunveen Kaur; Eliza G Miller; Amy E Larsen; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith
Journal:  FASEB J       Date:  2016-07-26       Impact factor: 5.191

10.  miR-26a mediates LC-PUFA biosynthesis by targeting the Lxrα-Srebp1 pathway in the marine teleost Siganus canaliculatus.

Authors:  Cuiying Chen; Shuqi Wang; Yu Hu; Mei Zhang; Xianda He; Cuihong You; Xiaobo Wen; Óscar Monroig; Douglas R Tocher; Yuanyou Li
Journal:  J Biol Chem       Date:  2020-08-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.